table of content
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnostics in Point of Care Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnostics in Point of Care Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnostics in Point of Care Overall Market Size
2.1 Global Molecular Diagnostics in Point of Care Market Size: 2022 VS 2029
2.2 Global Molecular Diagnostics in Point of Care Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnostics in Point of Care Players in Global Market
3.2 Top Global Molecular Diagnostics in Point of Care Companies Ranked by Revenue
3.3 Global Molecular Diagnostics in Point of Care Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnostics in Point of Care Companies in Global Market, by Revenue in 2022
3.5 Global Companies Molecular Diagnostics in Point of Care Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnostics in Point of Care Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnostics in Point of Care Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnostics in Point of Care Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Molecular Diagnostics in Point of Care Market Size Markets, 2022 & 2029
4.1.2 Polymerase Chain Reaction
4.1.3 In Situ Hybridization
4.1.4 Gene Chips
4.1.5 Next Generation Sequencing
4.2 By Type - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnostics in Point of Care Revenue, 2018-2023
4.2.2 By Type - Global Molecular Diagnostics in Point of Care Revenue, 2024-2029
4.2.3 By Type - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnostics in Point of Care Market Size, 2022 & 2029
5.1.2 Hospitals and Clinics
5.1.3 Independent Clinical Laboratories
5.2 By Application - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnostics in Point of Care Revenue, 2018-2023
5.2.2 By Application - Global Molecular Diagnostics in Point of Care Revenue, 2024-2029
5.2.3 By Application - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Molecular Diagnostics in Point of Care Market Size, 2022 & 2029
6.2 By Region - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnostics in Point of Care Revenue, 2018-2023
6.2.2 By Region - Global Molecular Diagnostics in Point of Care Revenue, 2024-2029
6.2.3 By Region - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Molecular Diagnostics in Point of Care Revenue, 2018-2029
6.3.2 US Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.3.3 Canada Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.3.4 Mexico Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnostics in Point of Care Revenue, 2018-2029
6.4.2 Germany Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.4.3 France Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.4.4 U.K. Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.4.5 Italy Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.4.6 Russia Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.4.7 Nordic Countries Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.4.8 Benelux Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnostics in Point of Care Revenue, 2018-2029
6.5.2 China Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.5.3 Japan Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.5.4 South Korea Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.5.5 Southeast Asia Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.5.6 India Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Molecular Diagnostics in Point of Care Revenue, 2018-2029
6.6.2 Brazil Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.6.3 Argentina Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnostics in Point of Care Revenue, 2018-2029
6.7.2 Turkey Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.7.3 Israel Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.7.4 Saudi Arabia Molecular Diagnostics in Point of Care Market Size, 2018-2029
6.7.5 UAE Molecular Diagnostics in Point of Care Market Size, 2018-2029
7 Molecular Diagnostics in Point of Care Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Molecular Diagnostics in Point of Care Major Product Offerings
7.1.4 Abbott Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 Accelerate Diagnostics
7.2.1 Accelerate Diagnostics Company Summary
7.2.2 Accelerate Diagnostics Business Overview
7.2.3 Accelerate Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.2.4 Accelerate Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.2.5 Accelerate Diagnostics Key News & Latest Developments
7.3 Ador Diagnostics
7.3.1 Ador Diagnostics Company Summary
7.3.2 Ador Diagnostics Business Overview
7.3.3 Ador Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.3.4 Ador Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.3.5 Ador Diagnostics Key News & Latest Developments
7.4 Beckman Coulter
7.4.1 Beckman Coulter Company Summary
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Molecular Diagnostics in Point of Care Major Product Offerings
7.4.4 Beckman Coulter Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.4.5 Beckman Coulter Key News & Latest Developments
7.5 Becton, Dickinson and Company
7.5.1 Becton, Dickinson and Company Company Summary
7.5.2 Becton, Dickinson and Company Business Overview
7.5.3 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Major Product Offerings
7.5.4 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.5.5 Becton, Dickinson and Company Key News & Latest Developments
7.6 Binx Health
7.6.1 Binx Health Company Summary
7.6.2 Binx Health Business Overview
7.6.3 Binx Health Molecular Diagnostics in Point of Care Major Product Offerings
7.6.4 Binx Health Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.6.5 Binx Health Key News & Latest Developments
7.7 Biocartis
7.7.1 Biocartis Company Summary
7.7.2 Biocartis Business Overview
7.7.3 Biocartis Molecular Diagnostics in Point of Care Major Product Offerings
7.7.4 Biocartis Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.7.5 Biocartis Key News & Latest Developments
7.8 bioM?rieux
7.8.1 bioM?rieux Company Summary
7.8.2 bioM?rieux Business Overview
7.8.3 bioM?rieux Molecular Diagnostics in Point of Care Major Product Offerings
7.8.4 bioM?rieux Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.8.5 bioM?rieux Key News & Latest Developments
7.9 Bio-Rad Laboratories
7.9.1 Bio-Rad Laboratories Company Summary
7.9.2 Bio-Rad Laboratories Business Overview
7.9.3 Bio-Rad Laboratories Molecular Diagnostics in Point of Care Major Product Offerings
7.9.4 Bio-Rad Laboratories Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.9.5 Bio-Rad Laboratories Key News & Latest Developments
7.10 Bosch Healthcare Solutions
7.10.1 Bosch Healthcare Solutions Company Summary
7.10.2 Bosch Healthcare Solutions Business Overview
7.10.3 Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Major Product Offerings
7.10.4 Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.10.5 Bosch Healthcare Solutions Key News & Latest Developments
7.11 Curetis
7.11.1 Curetis Company Summary
7.11.2 Curetis Business Overview
7.11.3 Curetis Molecular Diagnostics in Point of Care Major Product Offerings
7.11.4 Curetis Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.11.5 Curetis Key News & Latest Developments
7.12 Eurofins Scientific
7.12.1 Eurofins Scientific Company Summary
7.12.2 Eurofins Scientific Business Overview
7.12.3 Eurofins Scientific Molecular Diagnostics in Point of Care Major Product Offerings
7.12.4 Eurofins Scientific Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.12.5 Eurofins Scientific Key News & Latest Developments
7.13 Genetic Signatures
7.13.1 Genetic Signatures Company Summary
7.13.2 Genetic Signatures Business Overview
7.13.3 Genetic Signatures Molecular Diagnostics in Point of Care Major Product Offerings
7.13.4 Genetic Signatures Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.13.5 Genetic Signatures Key News & Latest Developments
7.14 Grifols
7.14.1 Grifols Company Summary
7.14.2 Grifols Business Overview
7.14.3 Grifols Molecular Diagnostics in Point of Care Major Product Offerings
7.14.4 Grifols Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.14.5 Grifols Key News & Latest Developments
7.15 Hibergene Diagnostics
7.15.1 Hibergene Diagnostics Company Summary
7.15.2 Hibergene Diagnostics Business Overview
7.15.3 Hibergene Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.15.4 Hibergene Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.15.5 Hibergene Diagnostics Key News & Latest Developments
7.16 Lumos Diagnostics
7.16.1 Lumos Diagnostics Company Summary
7.16.2 Lumos Diagnostics Business Overview
7.16.3 Lumos Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.16.4 Lumos Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.16.5 Lumos Diagnostics Key News & Latest Developments
7.17 Roche
7.17.1 Roche Company Summary
7.17.2 Roche Business Overview
7.17.3 Roche Molecular Diagnostics in Point of Care Major Product Offerings
7.17.4 Roche Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.17.5 Roche Key News & Latest Developments
7.18 Siemens
7.18.1 Siemens Company Summary
7.18.2 Siemens Business Overview
7.18.3 Siemens Molecular Diagnostics in Point of Care Major Product Offerings
7.18.4 Siemens Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.18.5 Siemens Key News & Latest Developments
7.19 Thermo Fisher Scientific
7.19.1 Thermo Fisher Scientific Company Summary
7.19.2 Thermo Fisher Scientific Business Overview
7.19.3 Thermo Fisher Scientific Molecular Diagnostics in Point of Care Major Product Offerings
7.19.4 Thermo Fisher Scientific Molecular Diagnostics in Point of Care Revenue in Global Market (2018-2023)
7.19.5 Thermo Fisher Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
